Supernus Pharmaceuticals buy klostergang
Start price
01.06.15
/
50%
€12.78
Target price
07.12.15
€17.00
Performance (%)
4.13%
End price
07.12.15
€13.30
Summary
This prediction ended on 07.12.15 with a price of €13.30. With a performance of 4.13%, the BUY prediction by klostergang for Supernus Pharmaceuticals closed with a slight gain. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Supernus Pharmaceuticals | 5.109% | 5.109% | 13.386% | 23.077% |
| iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
| iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
| iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
| iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by klostergang for this prediction
In the thread Supernus Pharmaceuticals diskutieren
Entwicklung und Vermarktung von Produkten für die Behandlung des Zentralnervensystems (ZNS):
Seit 2013 mit Oxtellar XR ® und Trokendi XR ®, zwei neuartige Neurologie Produkte für die Behandlung von Epilepsie, mit steigenden Verkaufszahlen.